Sphingosine Toxicity in EAE and MS: Evidence for Ceramide Generation via Serine-Palmitoyltransferase Activation

[1]  B. Engelhardt,et al.  Current multiple sclerosis treatments have improved our understanding of MS autoimmune pathogenesis , 2016, European journal of immunology.

[2]  S. Hunter.  Overview and diagnosis of multiple sclerosis. , 2016, The American journal of managed care.

[3]  O. Favorova,et al.  Pharmacogenetics of multiple sclerosis: personalized therapy with immunomodulatory drugs , 2016, Pharmacogenetics and genomics.

[4]  E. Mazzon,et al.  Purified Cannabidiol, the main non-psychotropic component of Cannabis sativa, alone, counteracts neuronal apoptosis in experimental multiple sclerosis. , 2015, European review for medical and pharmacological sciences.

[5]  M. Tohyama,et al.  Disturbance of Oligodendrocyte Function Plays a Key Role in the Pathogenesis of Schizophrenia and Major Depressive Disorder , 2015, BioMed research international.

[6]  Z. Berneman,et al.  Neuroendocrine Immunoregulation in Multiple Sclerosis , 2013, Clinical & developmental immunology.

[7]  T. Nakano,et al.  Sphingosine Induces Apoptosis in MKN-28 Human Gastric Cancer Cells in an SDK-Dependent Manner , 2012, Cellular Physiology and Biochemistry.

[8]  U. Ziemann,et al.  Ceramide Synthase 6 Plays a Critical Role in the Development of Experimental Autoimmune Encephalomyelitis , 2012, The Journal of Immunology.

[9]  U. Brunk,et al.  Sphingosine mediates TNFα-induced lysosomal membrane permeabilization and ensuing programmed cell death in hepatoma cells , 2012, Journal of Lipid Research.

[10]  N. Haughey.  Sphingolipids in Neurodegeneration , 2010, NeuroMolecular Medicine.

[11]  R. Kraft,et al.  TRPM3 is expressed in sphingosine‐responsive myelinating oligodendrocytes , 2010, Journal of neurochemistry.

[12]  K. Pahan,et al.  Sphingolipids in Multiple Sclerosis , 2010, NeuroMolecular Medicine.

[13]  V. Natarajan,et al.  Neurons and Oligodendrocytes Recycle Sphingosine 1-Phosphate to Ceramide , 2010, The Journal of Biological Chemistry.

[14]  H. Hartung,et al.  Mechanism of Action of Oral Fingolimod (FTY720) in Multiple Sclerosis , 2010, Clinical neuropharmacology.

[15]  J. Parratt,et al.  Multiple sclerosis: Distribution of inflammatory cells in newly forming lesions , 2009, Annals of neurology.

[16]  Saleh M. Ibrahim,et al.  Cytokines and Cytokine Profiles in Human Autoimmune Diseases and Animal Models of Autoimmunity , 2009, Mediators of inflammation.

[17]  R. Bittman,et al.  Ceramide Synthesis Is Modulated by the Sphingosine Analog FTY720 via a Mixture of Uncompetitive and Noncompetitive Inhibition in an Acyl-CoA Chain Length-de pend ent Manner* , 2009, The Journal of Biological Chemistry.

[18]  J. Garcia,et al.  FTY720 Inhibits Ceramide Synthases and Up-regulates Dihydrosphingosine 1-Phosphate Formation in Human Lung Endothelial Cells* , 2009, Journal of Biological Chemistry.

[19]  M. Tansey,et al.  Journal of Neuroinflammation BioMed Central Review , 2008 .

[20]  P. Calabresi,et al.  A defect of sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosis , 2008, Brain : a journal of neurology.

[21]  E. Bieberich,et al.  Regulation of neural progenitor cell motility by ceramide and potential implications for mouse brain development , 2008, Journal of neurochemistry.

[22]  Darpan I. Patel,et al.  Cytokine responses to acute and chronic exercise in multiple sclerosis. , 2008, Journal of applied physiology.

[23]  Yusuf A. Hannun,et al.  Principles of bioactive lipid signalling: lessons from sphingolipids , 2008, Nature Reviews Molecular Cell Biology.

[24]  S. Spicer,et al.  Cell‐specific expression of neutral glycosphingolipids in vertebrate brain: Immunochemical localization of 3‐O‐acetyl‐sphingosine‐series glycolipid(s) in myelin and oligodendrocytes , 2007, Journal of neuroscience research.

[25]  Wen Qin,et al.  Relapsing neuromyelitis optica and relapsing-remitting multiple sclerosis: differentiation at diffusion-tensor MR imaging of corpus callosum. , 2007, Radiology.

[26]  R. Yu,et al.  Tumor necrosis factor‐α up‐regulates glucuronosyltransferase gene expression in human brain endothelial cells and promotes T‐cell adhesion , 2007, Journal of neuroscience research.

[27]  E. Bieberich,et al.  Development and characterization of a novel anti-ceramide antibody Published, JLR Papers in Press, January 8, 2007. , 2007, Journal of Lipid Research.

[28]  J. Houghton,et al.  Sphingosine-induced apoptosis in rhabdomyosarcoma cell lines is dependent on pre-mitochondrial Bax activation and post-mitochondrial caspases. , 2007, Cancer research.

[29]  M. Cabot,et al.  Ceramides and other bioactive sphingolipid backbones in health and disease: lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy. , 2006, Biochimica et biophysica acta.

[30]  J. Woodcock.  Sphingosine and ceramide signalling in apoptosis , 2006, IUBMB life.

[31]  H. Groot,et al.  Cycloserine and threo-dihydrosphingosine inhibit TNF-α-induced cytotoxicity: evidence for the importance of de novo ceramide synthesis in TNF-α signaling , 2003 .

[32]  S. Payne,et al.  The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2 , 2003, FEBS letters.

[33]  Alfred H. Merrill,et al.  De Novo Sphingolipid Biosynthesis: A Necessary, but Dangerous, Pathway* , 2002, The Journal of Biological Chemistry.

[34]  E. Hogan,et al.  3-O-acetyl-sphingosine-series myelin glycolipids: characterization of novel 3-O-acetyl-sphingosine galactosylceramide. , 2002, Journal of lipid research.

[35]  Mingde Zhao,et al.  Sphingosine-induced apoptosis is dependent on lysosomal proteases. , 2001, The Biochemical journal.

[36]  M Filippi,et al.  Linking structural, metabolic and functional changes in multiple sclerosis , 2001, European journal of neurology.

[37]  S. Brahmbhatt,et al.  Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I , 2001, Nature Genetics.

[38]  Robert H. Brown,et al.  SPTLC1 is mutated in hereditary sensory neuropathy, type 1 , 2001, Nature Genetics.

[39]  E. Hogan,et al.  Chromatographic resolution and quantitative assay of CNS tissue sphingoids and sphingolipids. , 2001, Journal of lipid research.

[40]  G. Comi,et al.  Cytokine therapy in immune-mediated demyelinating diseases of the central nervous system: a novel gene therapy approach , 2000, Journal of Neuroimmunology.

[41]  E. Hogan,et al.  Combined TUNEL and double immunofluorescent labeling for detection of apoptotic mononuclear phagocytes in autoimmune demyelinating disease. , 2000, Brain research. Brain research protocols.

[42]  Y. Hannun,et al.  Serine Palmitoyltransferase Regulates de NovoCeramide Generation during Etoposide-induced Apoptosis* , 2000, The Journal of Biological Chemistry.

[43]  M. Clanet,et al.  Involvement of de novo ceramide biosynthesis in lymphotoxin-induced oligodendrocyte death. , 1999, Neuroreport.

[44]  H. Hartung,et al.  Effector pathways in immune mediated central nervous system demyelination. , 1999, Current opinion in neurology.

[45]  S. Hauser,et al.  Identification of autoantibodies associated with myelin damage in multiple sclerosis , 1999, Nature Medicine.

[46]  E. Hogan,et al.  Calpain activity and translational expression increased in spinal cord injury , 1999, Brain Research.

[47]  R. Kolesnick,et al.  Signal transduction of stress via ceramide. , 1998, The Biochemical journal.

[48]  Mushfiquddin Khan,et al.  Cytokine-mediated Induction of Ceramide Production Is Redox-sensitive , 1998, The Journal of Biological Chemistry.

[49]  R. Rudick,et al.  Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.

[50]  D. Zechner,et al.  Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death. , 1996, The Journal of clinical investigation.

[51]  H. Link,et al.  Review: cytokines and the pathogenesis of multiple sclerosis , 1996, Journal of neuroscience research.

[52]  N. Bhat,et al.  Activation of Mitogen‐Activated Protein Kinases in Oligodendrocytes , 1996, Journal of neurochemistry.

[53]  L. Eng,et al.  Inflammation in EAE: Role of chemokine/cytokine expression by resident and infiltrating cells , 1996, Neurochemical Research.

[54]  M Filippi,et al.  A Magnetization Transfer Imaging Study of Normal-Appearing White Matter in Multiple Sclerosis , 1995, Neurology.

[55]  M. Pender,et al.  Apoptosis in the nervous system in experimental allergic encephalomyelitis , 1991, Journal of the Neurological Sciences.

[56]  K. Sandhoff,et al.  Sphingolipid biosynthesis in cultured neurons. Down-regulation of serine palmitoyltransferase by sphingoid bases. , 1991, European journal of biochemistry.

[57]  M. Taniike,et al.  Study of pathogenesis in twitcher mouse, an enzymatically authentic model of Krabbe's disease , 1990, Journal of the Neurological Sciences.

[58]  Y. Hannun,et al.  Lysosphingolipids inhibit protein kinase C: implications for the sphingolipidoses. , 1987, Science.

[59]  H. Igisu,et al.  Analysis of galactosylsphingosine (psychosine) in the brain. , 1984, Journal of lipid research.

[60]  E. A. Moscatelli,et al.  Gas liquid chromatographic analysis of sphingosine bases in sphingolipids of human normal and multiple sclerosis cerebral white matter , 1969, Lipids.

[61]  M. Ameloot,et al.  Characterization of three human oligodendroglial cell lines as a model to study oligodendrocyte injury: Morphology and oligodendrocyte-specific gene expression , 2003, Journal of neurocytology.

[62]  H. de Groot,et al.  Cycloserine and threo-dihydrosphingosine inhibit TNF-alpha-induced cytotoxicity: evidence for the importance of de novo ceramide synthesis in TNF-alpha signaling. , 2003, Biochimica et biophysica acta.

[63]  N. Bhat,et al.  TNFalpha potentiates IFNgamma-induced cell death in oligodendrocyte progenitors. , 1998, Journal of neuroscience research.

[64]  N. Bhat,et al.  Neutral monoglycosylceramides in rat brain: occurrence, molecular expression and developmental variation. , 1997, Developmental neuroscience.

[65]  N. Yanagisawa,et al.  Expression of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 in the spinal cord of rats during acute experimental allergic encephalomyelitis. , 1994, Autoimmunity.

[66]  R. D. Williams,et al.  Enzymology of long-chain base synthesis by liver: characterization of serine palmitoyltransferase in rat liver microsomes. , 1984, Archives of biochemistry and biophysics.